Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Patient Advocacy Groups Submit Letter in Support of BIOSIM Act

Big Molecule Watch · July 9, 2021

Study Concludes Two Adalimumab Biosimilars may be as Safe and Effective as Originator

Big Molecule Watch · May 28, 2021

Meiji Announces Promising Phase I Results for Ustekinumab Biosimilar and Initiation of Phase III Clinical Trial

Big Molecule Watch · May 26, 2021

International Biosimilar Launches: Ujvira and PrInclunox®

Big Molecule Watch · May 26, 2021

Formycon and Biocon Biologics/Viatris Share Recent Biosimilars Development News

Big Molecule Watch · March 8, 2021